<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.sciencedaily.com/~d/styles/itemcontent.css"?><rss xmlns:media="http://search.yahoo.com/mrss/" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
	<channel>
		<title>Pharmaceuticals News -- ScienceDaily</title>
		<link>https://www.sciencedaily.com/news/health_medicine/pharmaceuticals/</link>
		<description>Research news on the pharmaceutical industry including new drugs and interventions.</description>
		<language>en-us</language>
		<pubDate>Sun, 06 Mar 2016 22:37:39 EST</pubDate>
		<lastBuildDate>Sun, 06 Mar 2016 22:37:39 EST</lastBuildDate>
		<ttl>60</ttl>
		<image>
			<title>Pharmaceuticals News -- ScienceDaily</title>
			<url>https://www.sciencedaily.com/images/scidaily-logo-rss.png</url>
			<link>https://www.sciencedaily.com/news/health_medicine/pharmaceuticals/</link>
			<description>For more science news, visit ScienceDaily.</description>
		</image>
		
		<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.sciencedaily.com/sciencedaily/health_medicine/pharmaceuticals" /><feedburner:info uri="sciencedaily/health_medicine/pharmaceuticals" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><feedburner:emailServiceId>sciencedaily/health_medicine/pharmaceuticals</feedburner:emailServiceId><feedburner:feedburnerHostname>https://feedburner.google.com</feedburner:feedburnerHostname><item>
			<title>Women need more of the HIV drug Truvada than men to prevent infection</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/82ulCNU9oV4/160304092014.htm</link>
			<description>Women need daily doses of the antiviral medication Truvada to prevent HIV infection while men only need two doses per week due to the way the drug accumulates in different body tissues, according to a new study from pharmacy researchers.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/82ulCNU9oV4" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Fri, 04 Mar 2016 09:20:14 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/03/160304092014.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/03/160304092014.htm</feedburner:origLink></item>
		<item>
			<title>Most teens who misuse prescription stimulants say they use other people's medication</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/subaDDFqt6M/160303120641.htm</link>
			<description>Using someone else's medication is the most common form of prescription stimulant misuse among adolescents, according to a study, which found that 88 percent of teens who used the drugs non-medically in the past 30 days said they had obtained the medications from someone else.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/subaDDFqt6M" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 03 Mar 2016 12:06:41 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/03/160303120641.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/03/160303120641.htm</feedburner:origLink></item>
		<item>
			<title>Key brain receptor sheds light on neurological conditions, researchers say</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/ROkkkUkiWdo/160303083823.htm</link>
			<description>Researchers have found that a key receptor in the brain, once thought to only strengthen synapses, can also weaken them, offering new insights into the mechanisms driving depression, drug addiction and even Alzheimer's disease.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/ROkkkUkiWdo" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 03 Mar 2016 08:38:23 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/03/160303083823.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/03/160303083823.htm</feedburner:origLink></item>
		<item>
			<title>Why pharmaceutical firms may prefer to invest in drugs over vaccines</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/CcOOek1RTM4/160302204516.htm</link>
			<description>When it comes to addressing disease, many industry observers and public health advocates believe that pharmaceutical companies prefer to invest in drugs rather than vaccines, as preventives are perceived to be inherently less profitable. A new study on preventives versus treatments offers a new economic rationale for this trend -- the population risk for diseases resembles a Zipf distribution, where the demand curve for a drug is likely to support stronger revenue extraction from a drug than for a vaccine.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/CcOOek1RTM4" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 02 Mar 2016 20:45:16 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/03/160302204516.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/03/160302204516.htm</feedburner:origLink></item>
		<item>
			<title>Drug combination slows breast cancer spread</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/NmuXOt5AuHY/160302204510.htm</link>
			<description>A combination of two drugs delays progression of advanced, aggressive breast cancer by an average of nine months -- working in all subsets of the most common type of breast cancer. The combination -- of a first-in-class targeted drug called palbociclib, and the hormone drug fulvestrant -- slowed cancer growth in around two thirds of women with advanced forms of the most common type of breast cancer.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/NmuXOt5AuHY" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 02 Mar 2016 20:45:10 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/03/160302204510.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/03/160302204510.htm</feedburner:origLink></item>
		<item>
			<title>Hair forensics could yield false positives for cocaine use</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/LjiZw2aVxU8/160302121042.htm</link>
			<description>Hair analysis has become standard practice for determining whether someone has abused illicit drugs. But some experts have questioned whether current methods to wash away external contaminants from samples might affect test results. Now one team confirms that for cocaine detection, a pretreatment step can cause the drug on the outside of a hair shaft to wash into it and potentially lead to falsely identifying someone as a drug user.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/LjiZw2aVxU8" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 02 Mar 2016 12:10:42 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/03/160302121042.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/03/160302121042.htm</feedburner:origLink></item>
		<item>
			<title>Studies explain adolescents' vulnerability to addictive drugs</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/yGJq4m5c3Eg/160301103108.htm</link>
			<description>Researchers have discovered one reason why adolescents are more prone to drug addiction than adults, with findings that could lead to new treatments for addictive disorders.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/yGJq4m5c3Eg" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 01 Mar 2016 10:31:08 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/03/160301103108.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/03/160301103108.htm</feedburner:origLink></item>
		<item>
			<title>Tracking the tracker: Long road for Pennsylvania's prescription drug monitoring program</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/QJr4CKEEomc/160301075306.htm</link>
			<description>Prescription drug abuse is at a crisis level in Pennsylvania. In this story, the history of the crisis and the long political path the Commonwealth took to build a prescription drug monitoring system for physician use is examined.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/QJr4CKEEomc" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 01 Mar 2016 07:53:06 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/03/160301075306.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/03/160301075306.htm</feedburner:origLink></item>
		<item>
			<title>TXA safe, effective to reduce blood loss in joint replacement surgery</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/3PAcg09ggfM/160301074249.htm</link>
			<description>Blood loss and the need for a blood transfusion are major concerns in joint replacement surgery, but a new use for an old drug is proving effective in reducing blood loss and transfusion rates, according to a study. The drug, tranexamic acid, or TXA, has been used for decades in heart surgery, to treat hemophilia and to stop excessive uterine bleeding.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/3PAcg09ggfM" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 01 Mar 2016 07:42:49 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/03/160301074249.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/03/160301074249.htm</feedburner:origLink></item>
		<item>
			<title>Using new drug screening tool, researchers identify potential treatments for Ewing Sarcoma</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/BpyjfUT4G5E/160229220651.htm</link>
			<description>In a first-of-its-kind-study, researchers have discovered and applied a new screening technique capable of testing thousands of potential drug compounds to see if those compounds can reverse abnormal DNA unwinding in Ewing sarcoma, a bone and soft tissue cancer that's most common in teens and young adults.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/BpyjfUT4G5E" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 29 Feb 2016 22:06:51 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160229220651.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160229220651.htm</feedburner:origLink></item>
		<item>
			<title>New insights into how antiarrhythmic drugs work</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/XTG6NTMPdII/160229152914.htm</link>
			<description>If you suffer from atrial fibrillation (AF) -- a condition where disorganized electrical signals cause the heart's upper chambers to contract quickly and irregularly -- your doctor may prescribe an antiarrhythmic drug. Now, researchers have new insight into how these drugs work. They found that multi-target drugs, which are the most commonly prescribed drugs to treat AF and are considered the most efficacious, may work by changing properties of the cell membrane.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/XTG6NTMPdII" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2016/02/160229152914.jpg" height="369" width="300" />
			<pubDate>Mon, 29 Feb 2016 15:29:14 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160229152914.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160229152914.htm</feedburner:origLink></item>
		<item>
			<title>Lower income Ontario seniors less likely to access newly approved drugs, study suggests</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/JjaPQHBYeXo/160229140136.htm</link>
			<description>Wealthier seniors in Ontario were prescribed a new blood thinner for a common heart rhythm abnormality 1.5 times more often than poorer seniors when the drug was first approved by Health Canada, a new study has found.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/JjaPQHBYeXo" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 29 Feb 2016 14:01:36 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160229140136.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160229140136.htm</feedburner:origLink></item>
		<item>
			<title>New target for reducing nerve pain identified</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/pCL1jmKNNxw/160229082131.htm</link>
			<description>A specific molecule involved in maintaining pain after a nerve injury has been identified and blocked in mice by researchers.Â These results reveal a promising therapeutic strategy for treating neuropathic pain.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/pCL1jmKNNxw" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2016/02/160229082131.jpg" height="127" width="300" />
			<pubDate>Mon, 29 Feb 2016 08:21:31 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160229082131.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160229082131.htm</feedburner:origLink></item>
		<item>
			<title>Making better enzymes and protein drugs</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/M5u9JKw8q-s/160229082124.htm</link>
			<description>Natural selection results in protein sequences that are only soluble to the level that is required to carry out its physiological function. However, in biotechnological applications, we need these proteins to survive concentrations that are up to 1000-fold higher that what naturally occurs, e.g. an antibody drug in the syringe prior to injection. Because of this, biotechnological and therapeutic applications of protein are often hampered or rendered impossible by the mismatch between the natural solubility of a protein and the requirements of the application. This raises the question whether the solubility of natural protein sequences could be improved without affecting their intended function.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/M5u9JKw8q-s" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 29 Feb 2016 08:21:24 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160229082124.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160229082124.htm</feedburner:origLink></item>
		<item>
			<title>Potential treatment for Huntington's disease, found effective, safe in mice, monkeys</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/U_qZ5cC7tEE/160226173155.htm</link>
			<description>A drug that would be the first to target the cause of Huntington's disease is effective and safe when tested in mice and monkeys, according to data released today. A study to test the drug in humans has begun.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/U_qZ5cC7tEE" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Fri, 26 Feb 2016 17:31:55 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160226173155.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160226173155.htm</feedburner:origLink></item>
		<item>
			<title>First in-human vaccine study for malaria caused by Plasmodium vivax</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/63RdS126sZ0/160226143949.htm</link>
			<description>Researchers recently published the results of testing a Plasmodium vivax malaria vaccine candidate in a human challenge model.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/63RdS126sZ0" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Fri, 26 Feb 2016 14:39:49 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160226143949.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160226143949.htm</feedburner:origLink></item>
		<item>
			<title>Drug discovery paradigm targets Tau protein aggregation linked to the Alzheimer's disease</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/tHDDPX0O-mk/160226115215.htm</link>
			<description>New research demonstrates novel drug discovery paradigm to target the aggregation of the Tau protein linked to the onset of Alzheimer's and other related neurodegenerative diseases.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/tHDDPX0O-mk" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Fri, 26 Feb 2016 11:52:15 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160226115215.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160226115215.htm</feedburner:origLink></item>
		<item>
			<title>Chemists expose side effects of antimalarial drug</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/Tlx5tM_H40g/160225140423.htm</link>
			<description>The drug chloroquine has long been used to treat malaria, but it is not without side effects. To better understand how chloroquine toxicity occurs, medical researchers set out to investigate what the drug binds to in human cells.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/Tlx5tM_H40g" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 25 Feb 2016 14:04:23 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160225140423.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160225140423.htm</feedburner:origLink></item>
		<item>
			<title>Immunotherapy improves cognition in patients with schizophrenia</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/wPcsNwUe7Fw/160225135854.htm</link>
			<description>A recent study of a handful of patients supports mounting evidence that targeted suppression of inflammation packaged with standard therapy can improve the cognitive ability of patients with schizophrenia, physician-scientists report.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/wPcsNwUe7Fw" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 25 Feb 2016 13:58:54 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160225135854.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160225135854.htm</feedburner:origLink></item>
		<item>
			<title>Maraviroc-containing regimens safe, tolerable when taken for HIV prevention</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/vnpUKDGlTsM/160224151211.htm</link>
			<description>Maraviroc, an oral drug used to treat HIV infection, is safe and well-tolerated when taken daily as pre-exposure prophylaxis to prevent HIV infection by HIV-uninfected men who have sex with men at increased risk for acquiring HIV.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/vnpUKDGlTsM" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 24 Feb 2016 15:12:11 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160224151211.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160224151211.htm</feedburner:origLink></item>
		<item>
			<title>Unconventional treatment strategy controls -- rather than eradicates -- cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/y4Bn4COXCn0/160224145608.htm</link>
			<description>Can we learn to live with--rather than kill--cancer? A new study suggests that frequent, low-dose chemotherapy that keeps tumor growth under control may be more effective than standard high-dose chemotherapy that seeks to eradicate cancer cells completely.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/y4Bn4COXCn0" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2016/02/160224145608.jpg" height="280" width="300" />
			<pubDate>Wed, 24 Feb 2016 14:56:08 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160224145608.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160224145608.htm</feedburner:origLink></item>
		<item>
			<title>Omega-3 fatty acids may lower breast cancer risk in postmenopausal obese women</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/W-VI1JrJtYk/160224101025.htm</link>
			<description>Omega-3 fatty acids may lower the risk of breast cancer in postmenopausal obese women, according to researchers. The protection likely comes from the fatty acids' anti-inflammatory effects, say authors.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/W-VI1JrJtYk" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 24 Feb 2016 10:10:25 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160224101025.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160224101025.htm</feedburner:origLink></item>
		<item>
			<title>DNA 'Trojan horse' smuggles drugs into resistant cancer cells</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/seF5dJtV4oU/160223171443.htm</link>
			<description>Drug-resistant leukemia cells absorb a drug and die, when the drug is hidden inside a capsule made of folded up DNA, report scientists. In this case, the invading force is a common cancer drug.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/seF5dJtV4oU" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 23 Feb 2016 17:14:43 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160223171443.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160223171443.htm</feedburner:origLink></item>
		<item>
			<title>Scientists pave way for new generation of superbug drugs</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/qMSIcDKGIAY/160222114931.htm</link>
			<description>Scientists are getting closer to solving the problem of antibiotic resistance. New research reveals the mechanism by which drug-resistant bacterial cells maintain a defensive barrier. The findings pave the way for a new wave of drugs that kill superbugs by bringing down their defensive walls rather than attacking the bacteria itself.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/qMSIcDKGIAY" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 22 Feb 2016 11:49:31 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160222114931.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160222114931.htm</feedburner:origLink></item>
		<item>
			<title>New inhalers to treat lung diseases</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/gSWoaxFUMrM/160222105507.htm</link>
			<description>Scientists are working to develop advanced dry powder inhalers to treat and prevent pulmonary diseases.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/gSWoaxFUMrM" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 22 Feb 2016 10:55:07 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160222105507.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160222105507.htm</feedburner:origLink></item>
		<item>
			<title>Bath salts difficult to detect in biological samples, study finds</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/qBtcyamhUlg/160219092218.htm</link>
			<description>Synthetic cathinones or 'Bath salts' continue to be popular among recreational drug users and a new study highlights the challenges associated with the detection of these drugs in biological evidence.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/qBtcyamhUlg" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Fri, 19 Feb 2016 09:22:18 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160219092218.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160219092218.htm</feedburner:origLink></item>
		<item>
			<title>Health provider awareness can curb prescription drug abuse</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/lGP2vC9dMzk/160218133513.htm</link>
			<description>Increasing health care providers' level of concern about prescription drug abuse in their communities may be an effective public health tool in fighting America's prescription drug abuse epidemic, according to a study.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/lGP2vC9dMzk" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 18 Feb 2016 13:35:13 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160218133513.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160218133513.htm</feedburner:origLink></item>
		<item>
			<title>Key hurdle overcome in the development of drug against cystic fibrosis</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/89bR1YwgWkc/160218114849.htm</link>
			<description>In people suffering from cystic fibrosis the CFTR protein is not located in the right place in mucus-producing cells: it remains inside the cell while it should be in the cell wall. Those cells secrete a tough mucus with serious consequences. However, researchers have now succeeded in conducting the CFTR to the cell walls.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/89bR1YwgWkc" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 18 Feb 2016 11:48:49 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160218114849.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160218114849.htm</feedburner:origLink></item>
		<item>
			<title>Diabetes drug may prevent recurring strokes</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/m1l88op1wtM/160217180251.htm</link>
			<description>Pioglitazone, a drug used for type 2 diabetes, may prevent recurrent stroke and heart attacks in people with insulin resistance but without diabetes. The results of the trial suggest a potential new method to prevent stroke and heart attack in high-risk patients who have already had one stroke or transient ischemic attack.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/m1l88op1wtM" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2016/02/160217180251.jpg" height="449" width="300" />
			<pubDate>Wed, 17 Feb 2016 18:02:51 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160217180251.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160217180251.htm</feedburner:origLink></item>
		<item>
			<title>Pairing pain medicine with metal ions to battle cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/jULf5cz2ono/160217130711.htm</link>
			<description>Fighting chemoresistant cancer remains a huge challenge that scientists are tackling from as many angles as they can. One alternative approach involves pairing two groups of compounds -- pain medicine and metal ions -- that have individually shown promise as anti-cancer agents. Scientists now report that combining the two led to new compounds that could destroy drug-resistant cancer cells and leave most normal cells alone in lab tests.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/jULf5cz2ono" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 17 Feb 2016 13:07:11 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160217130711.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160217130711.htm</feedburner:origLink></item>
		<item>
			<title>Immune-targeting drug combo shows promise for lung cancer patients</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/BFDqLqx5tpc/160217130701.htm</link>
			<description>Lung cancer is the most common cause of cancer-related death in the United States resulting in more than 158,000 deaths each year. Investigators initiated a multicenter phase 1b clinical trial to determine the safety and efficacy of a new drug combination for non-small cell lung cancer that stimulates a patient's immune system to target and kill cancer cells.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/BFDqLqx5tpc" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 17 Feb 2016 13:07:01 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160217130701.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160217130701.htm</feedburner:origLink></item>
		<item>
			<title>What is risk of mental health, substance use disorders if you use marijuana?</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/qV75_wtgnRM/160217112836.htm</link>
			<description>With more states legalizing marijuana for medical and recreational use, there are renewed clinical and policy concerns about the mental health effects of the drug.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/qV75_wtgnRM" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 17 Feb 2016 11:28:36 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160217112836.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160217112836.htm</feedburner:origLink></item>
		<item>
			<title>Clot removal may save money and limit disability</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/e9OJX0iiums/160217112825.htm</link>
			<description>Adding mechanical clot removal to clot-busting drugs could lower stroke survivors medical bills, decrease government healthcare as well as non-healthcare related costs, and increase the likelihood of the patient returning to work and participating in society, according to new research.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/e9OJX0iiums" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 17 Feb 2016 11:28:25 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160217112825.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160217112825.htm</feedburner:origLink></item>
		<item>
			<title>Scientists create vaccine against dangerous designer opioids</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/_wxQnnFJWMk/160216181713.htm</link>
			<description>With use of synthetic opioid 'designer drugs' on the rise, scientists have a new strategy to curb addiction and even prevent fatal overdoses. In a new study, the scientists report successful preclinical tests of a vaccine that prevents the synthetic opioid fentanyl -- which some drug dealers now use as a mix-in or substitute for heroin -- from reaching the brain.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/_wxQnnFJWMk" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 16 Feb 2016 18:17:13 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160216181713.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160216181713.htm</feedburner:origLink></item>
		<item>
			<title>Slight change to antibacterial drug may improve TB treatments</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/JM8HFAxqbOI/160216143457.htm</link>
			<description>One small chemical change to an existing antibacterial drug results in a compound that is more effective against its target enzyme in tuberculosis, researchers report.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/JM8HFAxqbOI" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 16 Feb 2016 14:34:57 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160216143457.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160216143457.htm</feedburner:origLink></item>
		<item>
			<title>Adderall misuse rising among young adults</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/sfsCWvDMxzk/160216142831.htm</link>
			<description>While the number of prescriptions for the stimulant Adderall has remained unchanged among young adults, misuse and emergency room visits related to the drug have risen dramatically in this group, new research suggests.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/sfsCWvDMxzk" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 16 Feb 2016 14:28:31 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160216142831.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160216142831.htm</feedburner:origLink></item>
		<item>
			<title>New anti-biofilm compounds show promise against drug-resistant bacteria linked to hospital infections</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/KSJUtJS5pv8/160216091145.htm</link>
			<description>A new class of anti-biofilm compounds derived from marine microorganisms has been discovered by researchers who report that these show promise against a drug-resistant bacterium commonly associated with hospital-acquired infections.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/KSJUtJS5pv8" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 16 Feb 2016 09:11:45 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160216091145.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160216091145.htm</feedburner:origLink></item>
		<item>
			<title>Discovery lays the foundation to expand personalized chemotherapy for leukemia patients</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/WlIsXW8ksss/160215114011.htm</link>
			<description>Scientists have concluded a study of how inherited genetic variations in the NUDT15 gene cause serious chemotherapy toxicity; findings point to potential genetics-guided precision medicine.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/WlIsXW8ksss" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2016/02/160215114011.jpg" height="188" width="300" />
			<pubDate>Mon, 15 Feb 2016 11:40:11 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160215114011.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160215114011.htm</feedburner:origLink></item>
		<item>
			<title>Drug development crisis linked to bad technology choices</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/RgaAb5qFJYY/160215090153.htm</link>
			<description>Despite lower costs and increased speed of research inputs, the budget for getting a drug to market is soaring. Researchers suggest that a focus on process efficiency has favoured experimental models with less validity, more than outweighing efficency benefits.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/RgaAb5qFJYY" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 15 Feb 2016 09:01:53 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160215090153.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160215090153.htm</feedburner:origLink></item>
		<item>
			<title>Expert opinion on how to address the skyrocketing prices of cancer drugs</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/VbGBZfNO0wo/160212091628.htm</link>
			<description>Many patients with cancer find themselves in great financial distress, in part because the costs of cancer-fighting drugs are skyrocketing. Is it possible to create public policy that will rein in these prices and cut patients' out-of-pocket costs? Not without significant tradeoffs, that could reduce patients' access to some cancer medications, says a physician, cancer researcher and health economist.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/VbGBZfNO0wo" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Fri, 12 Feb 2016 09:16:28 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160212091628.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160212091628.htm</feedburner:origLink></item>
		<item>
			<title>New study confirms different generics have equal efficacy when treating epilepsy</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/6oKAkMRBTSI/160212091626.htm</link>
			<description>A new study tested two generic lamotrigine (prescription antiepileptic) products and found no detectable difference in clinical effects among patients in the trial.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/6oKAkMRBTSI" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Fri, 12 Feb 2016 09:16:26 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160212091626.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160212091626.htm</feedburner:origLink></item>
		<item>
			<title>Combination drug targeting opioid system may help relieve treatment-resistant depression</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/_x90gzIrbbs/160212091543.htm</link>
			<description>A clinical trial of an experimental drug for treatment-resistant major depression finds that modulation of the endogenous opioid system may improve the effectiveness of drugs that target the action of serotonin and related monoamine neurotransmitters.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/_x90gzIrbbs" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Fri, 12 Feb 2016 09:15:43 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160212091543.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160212091543.htm</feedburner:origLink></item>
		<item>
			<title>Common antimalarial drug could be used to treat major injury</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/NHdJOGx5TEE/160211183954.htm</link>
			<description>A common anti-malarial drug Artesunate could be used to reduce organ failure following injury, according to an early study in rats. The repurposing of the affordable and safe drug could help save the lives of major trauma patients, and the promising results have already led to human clinical trials being planned for this year.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/NHdJOGx5TEE" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 11 Feb 2016 18:39:54 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160211183954.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160211183954.htm</feedburner:origLink></item>
		<item>
			<title>New approach offered to treating cocaine addiction</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/UswlGGdv9m0/160211082525.htm</link>
			<description>An FDA-approved drug used for diabetes and obesity may also reduce cocaine dependence, new research indicates. The drug, trade name Byetta, derives from a naturally occurring hormone called glucagon-like peptide-1, or GLP-1, which regulates feeding behavior. Knowing what they did about GLP-1, the research team turned to it as a possible treatment for cocaine addicts.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/UswlGGdv9m0" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 11 Feb 2016 08:25:25 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160211082525.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160211082525.htm</feedburner:origLink></item>
		<item>
			<title>Nanoparticle reduces targeted cancer drug's toxicity</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/AYRCBFgLcc0/160210165715.htm</link>
			<description>In one of the first efforts to date to apply nanotechnology to targeted cancer therapeutics, researchers have created a nanoparticle formulation of a cancer drug that is both effective and nontoxic -- qualities harder to achieve with the free drug.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/AYRCBFgLcc0" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2016/02/160210165715.jpg" height="193" width="300" />
			<pubDate>Wed, 10 Feb 2016 16:57:15 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160210165715.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160210165715.htm</feedburner:origLink></item>
		<item>
			<title>New hope in global race to beat malaria parasite's deadly new resistance</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/y4APi2ynSbs/160210134828.htm</link>
			<description>Scientists have made a major breakthrough in the global search for a new drug to beat the malaria parasite's growing resistance to first-defense treatments. The deadly mosquito-borne malaria parasite kills around 450,000 children every year. Resistance to the world's most effective antimalarial drug, artemisinin, has developed in South-East Asia, with fears it will soon reach Africa. The artemisinin resistant species has spread to six countries in five years.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/y4APi2ynSbs" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2016/02/160210134828.jpg" height="314" width="300" />
			<pubDate>Wed, 10 Feb 2016 13:48:28 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160210134828.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160210134828.htm</feedburner:origLink></item>
		<item>
			<title>Rise in marijuana in U.S. use not as high as previously reported</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/i2LJFuDsfN8/160210112104.htm</link>
			<description>Researchers report an estimated 12.5 percent of adults living in the United States use marijuana, but this research also shows that the rate of pot use did not double from 2002 to 2013 â as had been reported in the fall â but instead increased by about 20 percent. Meanwhile, the rate of problems related to the drug has remained steady.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/i2LJFuDsfN8" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 10 Feb 2016 11:21:04 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160210112104.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160210112104.htm</feedburner:origLink></item>
		<item>
			<title>Teaching neurons to respond to placebos as potential treatment for Parkinson's</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/Qi9PgbcZS2A/160209221142.htm</link>
			<description>Scientist have discovered a way to make neurons respond to a placebo (a medically ineffective treatment), in the same way as they would to medically effective treatment, according to a new study.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/Qi9PgbcZS2A" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2016/02/160209221142.jpg" height="188" width="300" />
			<pubDate>Tue, 09 Feb 2016 22:11:42 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160209221142.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160209221142.htm</feedburner:origLink></item>
		<item>
			<title>Oral capsule with bacterial spores may be effective treatment for recurrent C. difficile</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/ew2SyQctWg0/160209105412.htm</link>
			<description>Treatment with an oral capsule containing the spores of approximately 50 species of beneficial bacteria successfully prevented recurrence of C. difficile infection in patients with a history of multiple recurrent disease, a multi-institutional research team reports.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/ew2SyQctWg0" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 09 Feb 2016 10:54:12 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160209105412.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160209105412.htm</feedburner:origLink></item>
		<item>
			<title>Study shows promising safety results for anti-aging drug</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/nViqY0co3hY/160209105352.htm</link>
			<description>Minimal metabolic side effects have been documented after continuous, long-term treatment with encapsulated rapamycin in a marmoset (monkey) model. Results lead to new research grant to study efficacy.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/nViqY0co3hY" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 09 Feb 2016 10:53:52 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160209105352.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160209105352.htm</feedburner:origLink></item>
		<item>
			<title>Device hits pancreatic tumors hard with toxic 4-drug cocktail, sparing the body</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/u8BofnDd7-Q/160208213840.htm</link>
			<description>An implantable device can deliver a particularly toxic cocktail of drugs directly to pancreatic tumors to stunt their growth or in some cases, shrink them -- all while showing signs that the rest of the body would be spared toxic side effects, report investigators.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/u8BofnDd7-Q" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 08 Feb 2016 21:38:40 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160208213840.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160208213840.htm</feedburner:origLink></item>
		<item>
			<title>Engineers 3-D-print a new lifelike liver tissue for drug screening</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/qx0zphDlFXc/160208183028.htm</link>
			<description>A team led by engineers has 3-D-printed a tissue that closely mimics the human liver's sophisticated structure and function. The new model could be used for patient-specific drug screening and disease modeling. Researchers said the advance could help pharmaceutical companies save time and money when developing new drugs.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/qx0zphDlFXc" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2016/02/160208183028.jpg" height="107" width="300" />
			<pubDate>Mon, 08 Feb 2016 18:30:28 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160208183028.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160208183028.htm</feedburner:origLink></item>
		<item>
			<title>Restricting ketamine would have 'dire consequences' for surgery in low-resource countries, anesthesiologists warn</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/UrwMIkPUaSw/160208140721.htm</link>
			<description>Proposals to restrict access to ketamine by making it a "Schedule I" drug would have a major impact on the availability of anesthesia and surgery in low- to middle-income countries (LMICs)âwhere ketamine is often the only general anesthetic drug available, according to experts.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/UrwMIkPUaSw" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 08 Feb 2016 14:07:21 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160208140721.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160208140721.htm</feedburner:origLink></item>
		<item>
			<title>Using medical marijuana to stop seizures in kids</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/3qwkYoirfmQ/160208140604.htm</link>
			<description>Desperate for relief, parents are taking unusual steps to help children plagued with seizures. The relief, however, comes in a most unlikely form: marijuana.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/3qwkYoirfmQ" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 08 Feb 2016 14:06:04 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160208140604.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160208140604.htm</feedburner:origLink></item>
		<item>
			<title>Research finds no easy answers to use of drug screening for pain patients</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/fRGWRdcgR8s/160208124254.htm</link>
			<description>Doctors who treat patients suffering from chronic pain face a quandary, according to research. Monitoring patients through urine drug screenings, part of the standard protocol to ensure patient safety, is associated with an increase in the odds that the patients won't return for future treatment.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/fRGWRdcgR8s" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 08 Feb 2016 12:42:54 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160208124254.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160208124254.htm</feedburner:origLink></item>
		<item>
			<title>Researchers home in on why female newborns are better protected from brain injury</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/RQEUSGEdAx8/160204151136.htm</link>
			<description>In a new study, researchers show that a particular protein found in the brains of both male and female mice is present at higher levels in females, which offers them stronger protection against one type of brain injury.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/RQEUSGEdAx8" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2016/02/160204151136.jpg" height="301" width="300" />
			<pubDate>Thu, 04 Feb 2016 15:11:36 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160204151136.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160204151136.htm</feedburner:origLink></item>
		<item>
			<title>Dogs accelerate the advance of new cancer treatments for both pets and people</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/jVu0dUwLoi4/160204151058.htm</link>
			<description>A new review suggests integrating dogs with naturally occurring cancers into studies of new drug therapeutics could result in better treatments for our four-legged friends while helping inform therapeutic development for human cancers. The review hopes to close the gap between human and canine cancer research, and accelerate the knowledge developed by studying cancer in both people and pets, a field known as comparative oncology.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/jVu0dUwLoi4" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 04 Feb 2016 15:10:58 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160204151058.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160204151058.htm</feedburner:origLink></item>
		<item>
			<title>Functional MRI may help identify new, effective painkillers for chronic pain sufferers</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/Y7I2qP-zub4/160204121949.htm</link>
			<description>New research may allow new, more effective and safer pain medications to reach patients who suffer from chronic pain sooner.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/Y7I2qP-zub4" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 04 Feb 2016 12:19:49 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160204121949.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160204121949.htm</feedburner:origLink></item>
		<item>
			<title>Investigation casts doubt over trial used to support top-selling anti-clotting drug</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/hvmMOaZrmLw/160204042248.htm</link>
			<description>An investigation raises new concerns about the top-selling anti-clotting drug, rivaroxaban (Xarelto). The trial compared rivaroxaban with the older anti-clotting drug warfarin for preventing strokes in patients with irregular heartbeat (atrial fibrillation).&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/hvmMOaZrmLw" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 04 Feb 2016 04:22:48 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160204042248.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160204042248.htm</feedburner:origLink></item>
		<item>
			<title>Improvised naloxone nasal sprays lack evidence of absorption and effect</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/pharmaceuticals/~3/EwOtIiDw95c/160204042231.htm</link>
			<description>Naloxone hydrochloride is a medication that can reverse the effects of an opioid overdose. Recently, the US Food and Drug Administration (FDA) approved a nasal naloxone product to replace those improvised kits.The authors of a new study point out that there isn't enough information available on improvised nasal naloxone kits to warrant this level of acceptance.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/pharmaceuticals/~4/EwOtIiDw95c" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 04 Feb 2016 04:22:31 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160204042231.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160204042231.htm</feedburner:origLink></item>
	</channel>
</rss><!-- Page successfully written to cache. --><!-- cached Sun, 06 Mar 2016 22:37:01 EST -->
